Trulieve Cannabis (TCNNF) Gains from Investment Securities (2020 - 2026)

Trulieve Cannabis' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $14.1 million for Q1 2026.

• In Q1 2026, Gains from Investment Securities rose 175.59% year-over-year to $14.1 million; the TTM figure through Mar 2026 stood at $10.5 million (up 179.84% YoY), while the FY2025 annual figure was $1.5 million, up 108.01% from the prior year.
• Gains from Investment Securities was $14.1 million for Q1 2026 at Trulieve Cannabis, up from $969000.0 in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $102.8 million in Q3 2023 to a low of -$98.9 million in Q4 2023.
• Historically, Gains from Investment Securities has averaged $797647.5 across 5 years, with a median of $651932.0 in 2023.
• The sharpest annual moves came in 2023 and 2024: Gains from Investment Securities soared 5015.83% in 2023, then plunged 3376.26% in 2024.
• A 5-year view of Gains from Investment Securities shows it stood at -$4.0 million in 2022, then slumped by 2356.25% to -$98.9 million in 2023, then jumped by 80.32% to -$19.5 million in 2024, then jumped by 104.98% to $969000.0 in 2025, then soared by 1357.59% to $14.1 million in 2026.
• The last three Gains from Investment Securities figures came in at $14.1 million (Q1 2026), $969000.0 (Q4 2025), and $97000.0 (Q3 2025), per Business Quant data.